FIELD: chemistry.
SUBSTANCE: new pyrrolotriazine derivatives of general formula (I) 
are described, where R1 is possibly substituted piperidinyl or piperazinyl; R2 is possibly substituted phenyl; R3 is hydrogen; X is -NH-; Y is -CH2-; as well as their pharmaceutically acceptable salts or steroisomers, and pharmaceutical compositions containing said compounds.
EFFECT: given compounds are kinase inhibitors and can be used in medicine, for example as anticancer agents.
9 cl, 267 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| C-6 MODIFIED INDAZOLYL PYRROLOTRIAZINES | 2003 |
|
RU2356903C2 |
| METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
| OXADIAZOLE-BASED CHANNEL INHIBITORS WITH TRANSIENT POTENTIAL | 2019 |
|
RU2818244C2 |
| NOVEL (HETERO)ARYL-SUBSTITUTED PIPERIDINYL DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2017 |
|
RU2742271C2 |
| PYRIMIDINE COMPOUNDS FOR USE AS DELTA-OPIOID RECEPTOR MODULATORS | 2010 |
|
RU2568434C2 |
| COMPOSITIONS AND METHODS OF TREATING KIT- AND PDGFRα-MEDIATED DISEASES | 2020 |
|
RU2817354C2 |
| NEW KINASE INHIBITORS | 2003 |
|
RU2331642C2 |
| CD73 INHIBITOR, ITS PRODUCTION METHOD AND ITS USE | 2020 |
|
RU2787428C1 |
| PYRROLOTRIAZINE DERIVATIVES AS KINASE INHIBITOR | 2018 |
|
RU2726632C1 |
| SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | 2009 |
|
RU2506257C2 |
